Microbot Medical (MBOT) Competitors

$0.95
+0.02 (+2.15%)
(As of 05/14/2024 ET)

MBOT vs. NXGL, SSKN, PETV, GCTK, BTCY, TTOO, PSTV, NURO, MHUA, and OSA

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include NEXGEL (NXGL), STRATA Skin Sciences (SSKN), PetVivo (PETV), GlucoTrack (GCTK), Biotricity (BTCY), T2 Biosystems (TTOO), Plus Therapeutics (PSTV), NeuroMetrix (NURO), Meihua International Medical Technologies (MHUA), and ProSomnus (OSA). These companies are all part of the "surgical & medical instruments" industry.

Microbot Medical vs.

NEXGEL (NASDAQ:NXGL) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.

Microbot Medical has a net margin of 0.00% compared to Microbot Medical's net margin of -67.48%. Microbot Medical's return on equity of -52.79% beat NEXGEL's return on equity.

Company Net Margins Return on Equity Return on Assets
NEXGEL-67.48% -52.79% -31.54%
Microbot Medical N/A -164.13%-125.22%

2.2% of NEXGEL shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 27.2% of NEXGEL shares are owned by company insiders. Comparatively, 10.6% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

NEXGEL has higher revenue and earnings than Microbot Medical. NEXGEL is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NEXGEL$4.09M3.35-$3.16M-$0.55-4.00
Microbot MedicalN/AN/A-$10.74M-$1.08-0.88

Microbot Medical has a consensus price target of $7.00, indicating a potential upside of 637.62%. Given NEXGEL's higher probable upside, analysts plainly believe Microbot Medical is more favorable than NEXGEL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Microbot Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Microbot Medical received 345 more outperform votes than NEXGEL when rated by MarketBeat users. Likewise, 70.61% of users gave Microbot Medical an outperform vote while only 50.00% of users gave NEXGEL an outperform vote.

CompanyUnderperformOutperform
NEXGELOutperform Votes
1
50.00%
Underperform Votes
1
50.00%
Microbot MedicalOutperform Votes
346
70.61%
Underperform Votes
144
29.39%

In the previous week, NEXGEL had 6 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for NEXGEL and 2 mentions for Microbot Medical. NEXGEL's average media sentiment score of 0.43 beat Microbot Medical's score of 0.32 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Overall Sentiment
NEXGEL Neutral
Microbot Medical Neutral

NEXGEL has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.

Summary

Microbot Medical beats NEXGEL on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$13.67M$3.87B$5.04B$7.85B
Dividend YieldN/A2.01%36.92%3.93%
P/E Ratio-0.8811.21144.7115.77
Price / SalesN/A71.102,437.2982.21
Price / CashN/A46.9532.9929.98
Price / Book2.504.275.144.35
Net Income-$10.74M$4.82M$104.57M$216.67M
7 Day Performance4.23%1.16%0.62%1.64%
1 Month Performance-7.86%2.61%2.07%3.94%
1 Year Performance-20.92%19.18%5.34%9.96%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGL
NEXGEL
0.7052 of 5 stars
$2.21
+0.5%
N/A+41.0%$13.76M$4.09M-3.9519Gap Up
SSKN
STRATA Skin Sciences
1.5485 of 5 stars
$0.41
-2.4%
$3.80
+825.9%
-62.8%$14.66M$33.36M-1.3299Stock Split
News Coverage
Gap Up
PETV
PetVivo
0 of 5 stars
$0.72
-10.6%
N/A-70.3%$12.07M$920,000.00-0.8425Gap Down
GCTK
GlucoTrack
1.588 of 5 stars
$0.58
-23.6%
N/A+37.5%$15.55MN/A-1.576Short Interest ↓
Gap Up
High Trading Volume
BTCY
Biotricity
0.3998 of 5 stars
$1.20
flat
N/AN/A$11.30M$9.64M-0.8655Short Interest ↑
TTOO
T2 Biosystems
0.2024 of 5 stars
$3.24
-10.7%
$3.00
-7.4%
-85.2%$17.85M$7.19M0.00113Gap Down
High Trading Volume
PSTV
Plus Therapeutics
2.5266 of 5 stars
$2.13
+6.0%
$8.00
+275.6%
-49.8%$9.12M$4.91M-0.0620Gap Down
High Trading Volume
NURO
NeuroMetrix
0 of 5 stars
$4.40
flat
N/A-46.4%$8.76M$5.90M-0.7126Analyst Forecast
Gap Down
MHUA
Meihua International Medical Technologies
0 of 5 stars
$0.76
+11.8%
N/A-82.1%$19.02M$97.10M0.00626Gap Down
OSA
ProSomnus
2.2333 of 5 stars
N/A$2.33
+∞
-99.4%$8.18M$27.65M-0.30136News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:MBOT) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners